ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The compa...
MD Anderson Cancer Center, Houston, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Cedars Sinai, Los Angeles, California, United States
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
University of California - San Francisco, San Francisco, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
NYU - Langone Health, New York, New York, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
University of Minnesota, Minneapolis, Minnesota, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Dana- Farber Cancer Institute, Boston, Massachusetts, United States
University of California San Francisco, Benioff Children's Hospital, San Francisco, California, United States
Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Cedars-Sinai, Los Angeles, California, United States
University of California - San Francisco, San Francisco, California, United States
Northwestern, Chicago, Illinois, United States
Baptist Cancer Institute, Jacksonville, Florida, United States
Billings Clinic, Billings, Montana, United States
Signal Point Clinical Research Center, Middletown, Ohio, United States